Literature DB >> 12676540

SAG attenuates apoptotic cell death caused by simulated ischaemia/reoxygenation in rat cardiomyocytes.

A Chanalaris1, Y Sun, D S Latchman, A Stephanou.   

Abstract

Sensitive to apoptosis gene (SAG) is a novel RING finger protein that has been shown to be involved in protection against apoptotic cell death induced by oxidative stress in various cell types. As SAG has been previously shown to be expressed in the heart, we assessed its role in cardiac myocytes exposed to ischaemic stress. SAG expression was enhanced by hypoxia in neonatal cardiomyocytes as well as in the intact heart exposed to ischaemia/reperfusion. SAG levels remain elevated during the first 4 h of reoxygenation and return to control levels after 16 h of reoxygenation. We also show that overexpression of SAG in cardiac myocytes is able to protect against simulated ischaemia/reperfusion-induced apoptotic cell death. However, abrogation of the RING finger of the protein eliminates the anti-apoptotic properties of SAG. Furthermore, an antisense SAG construct enhances cell death, both in normoxic and hypoxic conditions. Hence, we conclude that SAG is a cardioprotective agent in cardiac cells exposed to ischaemic stress and an important protein involved in cardiomyocyte survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676540     DOI: 10.1016/s0022-2828(03)00003-8

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

1.  CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity.

Authors:  Hongbin He; Mingjia Tan; Deepika Pamarthy; Guixia Wang; Khalil Ahmed; Yi Sun
Journal:  Mol Cell Biochem       Date:  2006-07-28       Impact factor: 3.396

2.  SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.

Authors:  Mingjia Tan; Jayme R Gallegos; Qingyang Gu; Yuanhui Huang; Jun Li; Yetao Jin; Hua Lu; Yi Sun
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

Review 3.  E3 ubiquitin ligases as cancer targets and biomarkers.

Authors:  Yi Sun
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

4.  Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.

Authors:  Dongping Wei; Yi Sun
Journal:  Genes Cancer       Date:  2010-07

Review 5.  SCF E3 ubiquitin ligases as anticancer targets.

Authors:  L Jia; Y Sun
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

6.  Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking NF-kappaB activation in mouse embryonic stem cells.

Authors:  Mingjia Tan; Yueming Zhu; Jordan Kovacev; Yongchao Zhao; Zhen-Qiang Pan; Douglas R Spitz; Yi Sun
Journal:  Free Radic Biol Med       Date:  2010-06-08       Impact factor: 7.376

7.  Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Authors:  Dongping Wei; Meredith A Morgan; Yi Sun
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

8.  Role of E3 ubiquitin ligases in lung cancer.

Authors:  Barbara C Snoek; Leonie Ham de Wilt; Gerrit Jansen; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2013-08-10

Review 9.  Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.

Authors:  Yi Sun; Hua Li
Journal:  Protein Cell       Date:  2012-11-08       Impact factor: 14.870

10.  Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.

Authors:  Lijun Jia; Jie Yang; Xinbao Hao; Min Zheng; Hongbin He; Xiufang Xiong; Liang Xu; Yi Sun
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.